Stoke Therapeutics, Inc.

NASDAQ:STOK

15.14 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 4.8314.2162.8023.308-2.4815.1523.2692.9053.23130000000000000000
Kosten van de omzet 1.111.1131.2151.21.1671.1471.1520.9240.8350.6240.6210.5760.5260.507000000000000
Brutowinst 3.7213.1031.5872.108-3.6484.0052.1171.9812.3962.376-0.621-0.576-0.526-0.507000000000000
Brutowinstmarge 0.770.7360.5660.6371.470.7770.6480.6820.7420.7920000000000000000
Onderzoek- en ontwikkelingskosten 20.58821.80521.15420.27120.55119.63121.06120.10918.35818.30915.80214.35814.0959.9138.9048.1097.9687.2157.0896.5186.0234.1333.0042.2271.8881.252
Algemene en administratieve kosten 13.03710.2210.6110.27110.2310.2119.3839.94410.1119.4868.7248.3257.9346.9145.6825.6025.0444.523.9793.3242.4222.1891.5381.091.1220.66
Verkoop- en marketingkosten -0.562-0.55-0.59100000000000000000000000
Verkoop-, algemene en administratieve kosten 12.4759.6710.01910.27110.2310.2119.3839.94410.1119.4868.7248.3257.9346.9145.6825.6025.0444.523.9793.3242.4222.1891.5381.091.1220.66
Overige kosten -0.048-0.4280.0410.0410.0410.0420.0410.0420.0420.0420.0420.0420.0280.0160.0150.0160.0030.0220.0040.002-0.00300000
Bedrijfskosten 33.06331.47531.17330.54230.78129.84230.44430.05328.46927.79524.52622.68322.02916.82714.58613.71113.01211.73511.0689.8428.4456.3224.5423.3173.011.912
Bedrijfsresultaat -29.342-28.372-29.586-27.234-33.262-20.442-27.175-27.148-25.238-24.795-24.526-22.683-22.029-16.827-14.586-13.711-13.012-11.735-11.068-9.842-8.445-6.322-4.542-3.317-3.01-1.912
Bedrijfsresultaat ratio -6.074-6.73-10.559-8.23313.407-3.968-8.313-9.345-7.811-8.2650000000000000000
Totaal overige inkomsten en kosten netto 3.6471.9982.6280.0410.041-2.1031.521.0370.5860.1460.0420.0420.0280.0160.0150.0160.0030.0220.0040.002-0.0030.580.26000
Inkomen voor belasting -25.695-26.374-26.958-24.542-30.654-22.545-25.655-26.111-24.652-24.649-24.448-22.597-21.967-16.793-14.561-13.684-12.959-11.039-10.16-8.604-7.819-5.742-4.282-3.317-3.01-1.912
Inkomen voor belasting ratio -5.319-6.256-9.621-7.41912.356-4.376-7.848-8.988-7.63-8.2160000000000000000
Belastingkosten 01.0710.714-3.288-3.178-4.248-3.608-2.032-1.432-0.25-0.078-0.044-0.034-0.254-0.01-0.245-0.05-0.674-0.904-1.362-0.62900000
Nettowinst -25.695-26.374-26.958-24.542-30.654-18.297-22.047-24.079-23.22-24.399-24.448-22.597-21.967-16.793-14.561-13.684-12.959-11.039-10.16-8.604-7.819-5.742-4.282-3.317-3.01-1.912
Nettowinstmarge -5.319-6.256-9.621-7.41912.356-3.551-6.744-8.289-7.187-8.1330000000000000000
WPA (Winst Per Aandeel) -0.46-0.57-0.6-0.55-0.69-0.43-0.56-0.61-0.59-0.65-0.66-0.61-0.6-0.46-0.44-0.41-0.39-0.34-0.31-0.26-1.54-0.19-0.18-0.14-0.13-0.081
Verwaterde WPA -0.46-0.57-0.6-0.55-0.69-0.43-0.56-0.61-0.59-0.65-0.66-0.61-0.6-0.46-0.44-0.41-0.39-0.34-0.31-0.26-1.54-0.19-0.18-0.14-0.13-0.081
EBITDA -28.232-27.259-28.371-27.234-33.262-24.69-27.175-26.76-25.238-24.548-24.526-22.429-21.78-16.827-14.349-13.711-12.788-11.542-10.929-9.842-8.34-6.242-4.467-3.253-2.967-1.88
EBITDA ratio -5.844-6.466-10.125-8.23313.407-4.792-8.313-9.212-7.811-8.1830000000000000000